TRANSGENOMIC Aktie

0,88 EUR 0,1136%

Zu Ihrem Onlinebroker

kaufen verkaufen

TRANSGENOMIC Aktienkurs : 13.02. ( 15 Min. verzögert)
0,881 € Letzter Kurs	0,11% Veränderung	0,880 € Vortag	0,881 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,881 - 0,881 Tag	1,22 - 0,484 52 Wochen	0 Tag	209 Ø 52 Wochen	0,869 13.900 Stücke	0,903 13.900 Stücke

TRANSGENOMIC Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

10.02.

Trovagene: Built on Experience and Ready to Move Higher

Trovagene differentiates itself from competitors like Gen-Probe (GPRO), Sequenom (SQNM) and Transgenomic (TBIO.OB) by providing a non-invasive, safe, and inexpensive platform for disease detection that holds the potential to replace complex and...
07.02.

Transgenomic's Equity Financing Seems Like Overkill

On 1/6/12 Transgenomic Inc. (TBIO) filed an 8-K announcing a $3 million commitment by Third Security to purchase convertible promissory notes. Terms of...

07.02.

Real Estate - Leases

NEW HAVEN –– Transgenomic has leased 22459 square feet at Five Science Park, replacing a sublease with a direct lease. The company is a...
03.02.

Transgenomic Announces $22.0 Million Private Placement Financing

Transgenomic, Inc. (OTCBB:TBIO) today announced that it has entered into definitive agreements with institutional and other accredited investors to raise approximately $22.0 million in a private plac…
31.01.

Alight Planning Achieves Record Growth in 2011

Notable new customers included PerkinElmer, Transgenomic, Health Net Federal Services, Larkin Hospital, Bumrungrad Hospital, Northeastern University, University of the Pacific, The New School, Sundance Resources Limited,...